PRVA

Privia Health GroupD

Nasdaq / Health Care Equipment & Services

At close

2026-06-18

View Chart

AI scenario view

RankAlpha Sentiment CodexPost-earnings T+1

B+

Bull case

25%

Probability

Target price

$32.50

+37.3% vs current

Most likely

Base case

50%

Probability

Target price

$26.50

+12.0% vs current

B-

Bear case

25%

Probability

Target price

$20.50

-13.4% vs current

AI sentiment snapshot

Latest data as of 2026-05-08

AI commentary

Headline tone is modestly constructive because the company posted strong operational growth and maintained its 2026 framework while lifting attributed-lives guidance, but the print was not clean enough to remove caution given the GAAP EPS miss in trusted secondary coverage. Immediate analyst-revision evidence is still thin on this May 8, 2026 T+1 follow-up, so the setup remains a monitoring view rather than a strong post-earnings upgrade.

RankAlpha Sentiment Codex - 2026-05-08

Open post-earnings memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-22catalystInitial post-print read-through is constructive on revenue and operations, but analyst revision depth is still limited at T+1Medium impact

Trusted secondary coverage indicated revenue came in above consensus while EPS missed, which fits the mixed market read after the release. At this stage, the evidence supports monitoring for follow-through target changes or estimate revisions rather than assuming a durable re-rating, especially because the packet still shows thin analyst-reaction depth despite a median target of $32.5556.

2026-08-01eventQ1 execution was strong, but the print stayed mixed because EPS lagged while guidance mostly heldHigh impact

Privia's May 7 earnings release showed Q1 2026 revenue up 25.8% to $603.8 million, adjusted EBITDA up 36.3% to $36.7 million, implemented providers up 13.6% to 5,535, and attributed lives up 26.5% to 1.606 million. Management reiterated full-year 2026 guidance for most metrics and raised attributed-lives guidance to 1.60-1.625 million, but GAAP EPS was only $0.02 and net income fell year over year, keeping the setup more balanced than outright bullish [#8-K-2026-05-07].

2026-12-31catalystProvider and attributed-life scaling remains the core compounding leverHigh impact

Privia ended 2025 with 5,380 implemented providers and about 1.541 million attributed lives, then reported Q1 2026 growth to 5,535 providers and 1.606 million attributed lives. If same-store growth and new provider onboarding continue while care margin and platform contribution scale, the company retains a credible longer-duration value-based-care growth path [#10-K-2026-02-27] [#8-K-2026-05-07].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-08 • Updated nightlySource: Internal modelMethodology